India, Oct. 28 -- The Government of India has issued a release:
Company Name
Drug Name
Strength & Dosage Form
Brand Name
Pack Size
Old MRP (Rs.)
Revised MRP (Rs.)
RPG LIFE SCIENCES LTD
Anastrozole
1 MG Tablet
ANARZOLE
10 tablets
695.76
73.00
Dr. Reddys Laboratories Limited
Azacitidine
100 MG Injection
Azacytin
1
6,337.00
1,495.04
Abbott Healthcare Pvt. Ltd.
Bevacizumab
100 mg/4 ml Injection
BEVACIZAB
4 ml vial
21,767.70
5,930.13
NATCO PHARMA LIMITED
Dasatinib
20 MG Tablet
Dasanat 20
60 tablets
2,812.50
1,085.93
RPG LIFE SCIENCES LTD
Denosumab
60 MG Injection
Debrumab 60 mg
1 ml PFS
22,031.25
5,941.00
RPG LIFE SCIENCES LTD
Enzalutamide
40 MG Capsule
Enuta
28 capsules
6,578.20
2,232.00
NEON LABORATORIES LIMITED
Erlotinib
150 MG Tablet
ERLIB
1 Plastic Bottle of 30 tablets
4,637.45
2,008.00
HETERO HEALTHCARE LTD
Fludarabine
50 MG Injection
FLUDANOX
vial
14,235.00
2,432.00
RPG LIFE SCIENCES LTD
Fulvestrant
50 MG Injection
Fulbreca
5 ml vial
26,072.16
5,491.00
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has released a list of 543 brands of anti cancer medicines with their revised Maximum Retail Price (MRP). The revised MRPs will be effective from November 9, 2026. The revised price list reflects the information submitted by companies up to October 27, 2026 and it will be updated as and when manufacturers submit their revised prices of non-scheduled anti-cancer drugs.
Some brands of the anti cancer medicines with their pre-revised and revised prices:
The complete list of 543 brands of Anti-Cancer medicines with revised MRPs is available here. (LINK). The NPPA portal is updated on a continual basis.
On October 17, 2026, NPPA had announced Trade Margin Rationalisation (TMR) of 137 non-scheduled anti-cancer drugs in public interest to address excessive trade margins, make cancer treatment more affordable and improve access to anti-cancer medicines. Manufacturers were instructed to submit their revised list to NPPA.
The 137 non-scheduled anti-cancer drugs include immunotherapy medicines used in the treatment of over 20 types of cancer, Denosumab used by breast and prostate cancer patients, Pegfilgrastim used to prevent neutropenia in cancer patients, and Bevacizumab, which is approved for the treatment of colon, ovarian and cervical cancers.
Disclaimer: Curated by HT Syndication.
